Functional improvement in children and adolescents with primary headache after an interdisciplinary multimodal therapy program: the DreKiP study

• Published in: Journal of headache and pain Vol. 23; no. 1; p. 109
• Main Authors: Sobe, Hanna, Richter, Matthias, Berner, Reinhard, von der Hagen, Maja, Hähner, Antje, Röder, Ingo, Koch, Thea, Sabatowski, Rainer, Klimova, Anna, Gossrau, Gudrun
• Format: Journal Article
• Language: English
• Published: Milan Springer Milan 01.12.2022; Springer Nature B.V; BMC
• Subjects: Adolescents; Children; Headache; Headaches; Interdisciplinary aspects; Internal Medicine; Medicine; Medicine & Public Health; Migraine; Neurology; Pain Medicine; Patients; Pediatrics; Teenagers; Therapy program; Headache; Therapy program; Children
• ISSN: 1129-2369; 1129-2377
• DOI: 10.1186/s10194-022-01481-1

Background More than 2/3 of children and adolescents in Germany regularly suffer from headaches. Headache-related limitations in everyday life, school drop-out and educational impairment are common. Structured therapy programs for young headache patients are widely missing. Methods One hundred eleven patients with frequent migraine and/or tension type headache were treated in a 15 hour group program in afternoons, parallel with school, parents received 7 hours of therapy. At the beginning of the program (T0), 6 (T1) and 12 months (T2) after completion, data on headache related disability (PedMidas), headache frequency, intensity, and pediatric pain disability score (PPDI) were prospectively collected to investigate the effects of the therapy. Results Seventy-five patients (9-19 years, median = 14; 66.7% female) and their parents provided patient reported outcome measures showing at T1 (65 patients) and T2 (47 patients) reduced headache frequency (last 3 months headache days median T0: 30 days; T1: 18 days, reduction of median 12 days since T0; T2: 13 days, reduction of median 17 days since T0). Linear mixed models revealed significant reduction (T0/T1 p  = 0,002; T0/T2 p = 0,001). Reduced headache disability has been reported at T1 and T2 (PedMidas median T0 = 30, T1 = 15, T2 = 7; p  < 0,001, p < 0,001 respectively). Follow up data of a subgroup of patients 24 months after the treatment point to sustainable effects. Conclusions The interdisciplinary multimodal headache therapy program DreKiP reduces headache frequency and headache related disability significantly 6-12 months following its completion. Trial registration DRKS00027523, retrospectively registered.